“Learn how MDSAP simplifies the global regulatory audit process for medical device manufacturers, reducing costs, time, and improving efficiency across multiple countries.”
“What is MDSAP and How Does It Work?”
In simple terms, the Medical Device Single Audit Program (MDSAP) is a program created by the International Medical Device Regulators Forum (IMDRF), to minimize the number of regulatory audits that medical device manufacturers are required to undergo when they market their devices in several countries. To expedite the process, this program allows manufacturers to undergo one single audit meeting regulatory requirements of different countries involved in the program, so they do not face numerous audits from other regulatory bodies.
“Key Benefits of MDSAP for Medical Device Manufacturers”
MDSAP was created to take advantage for regulatory authorities as well as medical device manufacturers. The program advances international convergence of medical device regulation and standards among regulatory authorities, enabling them to share resources and minimize the burden of multiple audits. The program simplifies the regulatory audit process for manufacturers, minimizes audit costs and time, and improves efficiency.
Currently, MDSAP is recognized by five countries namely the USA, Canada, Brazil, Japan, and Australia. MDSAP – which allows manufacturers to meet the regulatory requirements of multiple regulatory authorities with a single audit – has specific regulatory steps for each one. MDSAP audits include areas of the Quality Management System (QMS), medical device adverse event and advisory notice reporting, corrective and preventive actions (CAPA), design and development, and production and service controls.
“The Role of Quality Management Systems (QMS) in MDSAP Audits”
This evaluation of QMS from the user-end ensures that the QMS meets regulation by the manufacturer and is implemented correctly. Equally, manufacturers should inform the regulatory authorities about suspicious adverse events and advisory notices concerning their medical devices, and an MDSAP audit evaluates whether adequate processes have been implemented to identify and report those. It also assesses the processes the manufacturer has in place for identifying, documenting and completing corrective and preventative actions.
“Understanding Adverse Event Reporting and CAPA in MDSAP Audits”
During MDSAP audits, the design and development processes of the manufacturer are evaluated to check their adherence to regulatory requirements along with proper implementation. It also assesses how well a manufacturer manages its processes to make the product, and services it to be compliant with regulations and to ensure safe and effective product.
“How to Choose an Auditing Organization for MDSAP”
Established by the International Medical Device Regulators Forum (IMDRF), MDSAP audits are performed by a contracted organization that has been granted assessment authority from each of the regulatory authorities that are part of this program. For the MDSAP audit, manufacturers need to choose a recognized auditing organization. Following the audit, a report is released by the auditing body for regulatory agencies in countries taking part. An MDSAP certificate, which is accepted by all of the participating countries, is then issued to the manufacturer if such a program should pass without issue.
Conclusion: “The Impact of MDSAP on Audit Costs and Time Efficiency”
On a final note, MDSAP is a program that should ease the audit process of regulatory environments for medical device manufacturers selling in more than one country. Performing a single audit that meets the regulatory standards of several nations will reduce cost and time for audits for manufacturers, improving efficiency and further supporting medical device regulation and standard international harmonization.
Reach out to BioBoston Consulting or visit our website to learn how we can help your organization.
